Indoco Remedies
INDOCONSE

Indoco Remedies

₹204.29-7.43 (3.51%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
203.23
Today’s high
212.99
52 week low
162.19
52 week high
349.80
Open price
212.01
Previous close
211.72
Live volume
94,751
Lower circuit
169.38
Upper circuit
254.06

Fundamentals

Market Cap
₹1,950Cr
ROE
-10.13%
P/E Ratio(TTM)
--
EPS(TTM)
-10.69
P/B Ratio
2.08
Dividend Yield
0.09%
Industry P/E
34.63
Book Value
101.76
Debt to Equity
1.16
Face Value
2

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹476
+6.55%
Profit (Cr)
-₹23.68
+19.59%
-2000200400600
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+21%
3Y CAGR+3%
Profit growthValue
1Y (TTM)+75%

About

Indoco Remedies Limited is a pharmaceutical firm engaged in manufacturing and marketing formulations and Active Pharmaceutical Ingredients for domestic and international markets. The company's mission is to improve the quality of human life by enabling people to do more, feel better, and live longer. To achieve this, it provides resources like financial aid and medicines to non-profit organizations, focusing on innovative and sustainable programs. In India, Indoco holds a strong position in various therapeutic segments, including Gastroenterology, Dentistry, Stomatology, and Respiratory care medicines. As part of its international strategy, the company acquired an 85% stake in Florida Pharmaceutical Product (FPP) in the USA to serve as its front-end arm. The company demonstrated robust performance, delivering 8% growth with revenues reaching ₹1762 crores for the year.;
CEO/MD
MS. ADITI PANANDIKAR
Founded in
1947
NSE symbol
INDOCO

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
58.86%
Retail And Others
22.04%
Mutual Funds
17.54%
Foreign Institutions
0.94%
Other Domestic Institutions
0.61%

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹425.85
+1.55 (0.37%)
L
    H
    3,969.4444.295.44
    ₹357.10
    +1.50 (0.42%)
    L
      H
      3,883.5281.1814.69
      Orchid PharmaORCHPHARMA
      ₹707.55
      -7.75 (1.08%)
      L
        H
        3,637.32192.782.86
        ₹121.17
        +1.63 (1.36%)
        L
          H
          3,508.8330.262
          Livesquawk
          Indoco Remedies reports Q4 consolidated net loss of 216M vs 404M YoY.
          Livesquawk
          Indoco Remedies cleared USFDA pre-approval inspection at Chhatrapati Sambhaji Nagar site. The inspection concluded with no Form 483 observations reported.
          2026
          7
          May
          Annual Result
          Release date
          3
          Feb
          Quarterly Result
          Release date
          2025
          6
          Nov
          Quarterly Result
          Release date

          4
          Sep
          Dividend
          Ex date
          ₹0.20
          per share

          For each share you hold, you will receive ₹0.20
          Dividend amount₹0.20 per share
          Dividend TypeFinal
          Ex Date4 Sep ‘25
          Record Date4 Sep ‘25
          Announcement date22 May ‘25
          24
          Jul
          Quarterly Result
          Release date

          22
          May
          Dividend
          Announced
          ₹0.20
          per share

          For each share you hold, you will receive ₹0.20
          Dividend amount₹0.20 per share
          Dividend TypeFinal
          Ex Date4 Sep ‘25
          Record Date4 Sep ‘25
          Announcement date22 May ‘25
          2024

          19
          Sep
          Dividend
          Ex date
          ₹1.50
          per share

          For each share you hold, you will receive ₹1.50
          Dividend amount₹1.50 per share
          Dividend TypeFinal
          Ex Date19 Sep ‘24
          Record Date19 Sep ‘24
          Announcement date16 May ‘24
          Events calendar
          View upcoming events in other stocks